Stock Comparison

RARE vs AAPL

Side-by-side fundamentals, quality, value, and price momentum analysis.

Tickers 2 / 10100+ Metrics

Selected Stocks

Add up to 10 tickers. Use presets or search to get started.

2 / 10
Quick presets:

Metrics Comparison

Best values highlighted in green, worst in red. Scroll horizontally to see all tickers.

MetricRAREUltragenyx Pharmaceutical Inc.AAPLApple Inc.
Market Cap$2.32B$3.82T
Current Price$24.07$259.96
P/E Ratio-3.8334.85
Revenue Growth 1Y29%6.4%
Net Margin-101.6%26.9%
ROE-211.7%171.4%
ROIC-343.7%70.6%
Debt/Equity0.151.34
FCF Yield2.6%
Dividend Yield0.4%
Loading chart...

RARE vs AAPL: Key Questions Answered

Which stock is growing the fastest: RARE or AAPL?

Ultragenyx Pharmaceutical Inc. (RARE) is growing the fastest with 29.0% revenue growth. Apple Inc. has the slowest growth at 6.4%. Higher growth often justifies higher valuations.

Which has the best profit margins: RARE or AAPL?

Apple Inc. (AAPL) has the strongest profitability with a 26.9% net margin. Ultragenyx Pharmaceutical Inc. has the lowest at -1.0%. Higher margins indicate pricing power and efficiency.

Which is the largest company: RARE or AAPL?

Apple Inc. (AAPL) is the largest company with a market cap of $3.82T. Ultragenyx Pharmaceutical Inc. is the smallest at $2.3B. Larger companies tend to be more stable but may have less growth potential.

Which stock has the best return on equity: RARE or AAPL?

Apple Inc. (AAPL) generates the best returns on shareholder equity with an ROE of 1.7%. Ultragenyx Pharmaceutical Inc. has the lowest at -2.1%. Higher ROE indicates efficient use of capital.